ACG APP GI Training Series

Welcome to the ACG APP GI Training Series. The series includes modules for various GI and Hepatology content areas. The series is designed to be completed either as a full series or as individual topics. APPs and the leaders in their practice should consider what modules may best suit the needs of the learner. The modules are structured to maximize learning and allow the participants to identify key diagnostics and treatments for patients within each of the content areas.

(1) Colon Module

Content Type: Presentations

(2) The Basics of IBD Module

Content Type: Presentations

(3) GI Bleeding Module

Content Type: Presentations

(4) Esophagus Module

Content Type: Presentations

(5) Pancreaticobiliary Module

Content Type: Presentations

(6) Stomach Module

Content Type: Presentations

(7) Small Bowel Module

Content Type: Presentations

Accreditation & CME Information

The American College of Gastroenterology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American College of Gastroenterology designates these enduring materials for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To obtain CME credit, you must thoroughly watch and listen to the recorded presentation, reflect on the activity, answer the assessment questions (all questions must be answered correctly), and complete the evaluation for each activity.  The designated credit hours for each activity are indicated prior to the beginning of the content.

The ACG Education Universe was released by ACG for web-based learning on April 1, 2006. The dates of original release, termination (after which the content is no longer valid for CME) and most recent review are posted with each material in the ACG Education Universe.

Disclosure Information

ACG staff involved in this activity have no relevant financial relationship(s) with ineligible companies to disclose.

Individual faculty and moderator disclosures will be listed prior to the start of each lecture.

APP Module Planners:
Sarah Enslin, PA-C: Ms. Enslin has indicated no relevant financial relationships
Janet Gripshover, CRNP: Speaker’s Bureau: AbbVie, Gilead Sciences, Intercept
Victoria Howard, PA: Ms. Howard has indicated no relevant financial relationships
Rhonda Jankovich, NP: Ms. Jankovich has indicated no relevant financial relationships
Michele Kissous-Hunt, PA-C: Advisory Board: AbbVie, Janssen; Board of Directors: Crohn’s Colitis Foundation National Board Trustee; Royalties: UpToDate; Speaker’s Bureau: AbbVie, BMS, Janssen, Pfizer, Takeda
Lenore Lamanna, ANP: Ms. Lamanna has indicated no relevant financial relationships
Karen Luken, NP: Ms. Luken has indicated no relevant financial relationships
Keisa Lynch, DNP, APRN, FNP: Speaker’s Bureau: Gilead
Sharon Magalona, NP: Advisory Board: Brystol Myers Squibb, Salix, Speaker’s Bureau: Pfizer, Takeda
Gabriella McCarty, NP: Speaker’s Bureau: AbbVie
Gina Mileo, NP: Ms. Mileo has indicated no relevant financial relationships
Nicole Mitchell, NP: Ms. Mitchell has indicated no relevant financial relationships
Monica Nandwani, NP: Advisory Board: Phathom Pharmaceuticals; Speaker’s Bureau: GHAPP
Sarah O’Neil, PA: Advisory Board: AbbVie
Kimberly Orleck, PA-C: Advisory Board: AbbVie, Phathom, Takeda; Speaker’s Bureau: AbbVie, Bristol Myers, Janssen
Karen Perls, PA: Ms. Perls has indicated no relevant financial relationships
Jannine Purcell, CNP: Ms. Purcell has indicated no relevant financial relationships
Alfred Reyno, PA: Mr. Reyno has indicated no relevant financial relationships
Shayla Schoenoff, PA: Advisory Board: AbbVie
Leslie Shaw, PA-C: Ms. Shaw has indicated no relevant financial relationships
Sarah Sherman, NP: Speaker’s Bureau: AbbVie
Jason Thomas, PA: Mr. Thomas has indicated no relevant financial relationships
Mary Vetter, ANP: Ms. Vetter has indicated no relevant financial relationships
Margaret Walker, PA: Ms. Walker has indicated no relevant financial relationships
All of the relevant financial relationships listed for these individuals have been mitigated.